09:5509:55, 29 April 2018diffhist+507
Hypohidrotic ectodermal dysplasia
→EDA (X-linked): First draft of A Phase 2 Open-label, Dose-escalation Study to Evaluate the Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200, an EDA-A1 Replacement Protein, Administered to Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)Tag: Visual edit
04:1804:18, 20 April 2017diffhist−165
Carrier Strike Group 1
The news in question is unfolding and the sentence was totally ambigious about what the news actually was. Also if the deployment news should be on the page it should have its own section.Tag: Visual edit
09:5509:55, 29 April 2018diffhist+507
Hypohidrotic ectodermal dysplasia
→EDA (X-linked): First draft of A Phase 2 Open-label, Dose-escalation Study to Evaluate the Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200, an EDA-A1 Replacement Protein, Administered to Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)Tag: Visual edit
04:1804:18, 20 April 2017diffhist−165
Carrier Strike Group 1
The news in question is unfolding and the sentence was totally ambigious about what the news actually was. Also if the deployment news should be on the page it should have its own section.Tag: Visual edit